Advent and maturation of regenerative medicine.

Abner M. Mhashilkar, Anthony Atala

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The field of regenerative medicine (RM), encompassing stem cell (SC) technologies, therapeutics, tissue engineering (TE), biomaterials, scaffolds and other enabling technologies provides a wide gamut of tools and tracks to combat, manage and hopefully cure serious human and animal injuries, dysfunctions and diseases. This review illustrates the trends that are becoming the major platforms in this field. The last 10 years in itself has seen major definitive observations, including multi-track directives of adult stem cell translational technologies, tissue and organ engineering protocols, iPS cell applications and understanding of the role of cancer stem cells to develop effective anti-cancer regimens. With the rapid advances of RM translational research, further advances are expected to be implemented for personalized repair and curative outcomes. RM future is bright although laden with challenges of global fragmentation which needs coherent consolidation, stringent cost and time effective regulation and long-term funding mechanisms, so clinical and diagnostic solutions are realized and recognized to combat unmet medical needs.

Original languageEnglish
Pages (from-to)430-445
Number of pages16
JournalCurrent stem cell research & therapy
Volume7
Issue number6
StatePublished - Nov 1 2012
Externally publishedYes

Fingerprint

Regenerative Medicine
Tissue Engineering
Technology
Adult Stem Cells
Translational Medical Research
Neoplastic Stem Cells
Biocompatible Materials
Stem Cells
Costs and Cost Analysis
Wounds and Injuries
Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Medicine (miscellaneous)

Cite this

Mhashilkar, A. M., & Atala, A. (2012). Advent and maturation of regenerative medicine. Current stem cell research & therapy, 7(6), 430-445.

Advent and maturation of regenerative medicine. / Mhashilkar, Abner M.; Atala, Anthony.

In: Current stem cell research & therapy, Vol. 7, No. 6, 01.11.2012, p. 430-445.

Research output: Contribution to journalArticle

Mhashilkar, AM & Atala, A 2012, 'Advent and maturation of regenerative medicine.', Current stem cell research & therapy, vol. 7, no. 6, pp. 430-445.
Mhashilkar, Abner M. ; Atala, Anthony. / Advent and maturation of regenerative medicine. In: Current stem cell research & therapy. 2012 ; Vol. 7, No. 6. pp. 430-445.
@article{2d5fb0050623447ea5eaa0e92acae7f4,
title = "Advent and maturation of regenerative medicine.",
abstract = "The field of regenerative medicine (RM), encompassing stem cell (SC) technologies, therapeutics, tissue engineering (TE), biomaterials, scaffolds and other enabling technologies provides a wide gamut of tools and tracks to combat, manage and hopefully cure serious human and animal injuries, dysfunctions and diseases. This review illustrates the trends that are becoming the major platforms in this field. The last 10 years in itself has seen major definitive observations, including multi-track directives of adult stem cell translational technologies, tissue and organ engineering protocols, iPS cell applications and understanding of the role of cancer stem cells to develop effective anti-cancer regimens. With the rapid advances of RM translational research, further advances are expected to be implemented for personalized repair and curative outcomes. RM future is bright although laden with challenges of global fragmentation which needs coherent consolidation, stringent cost and time effective regulation and long-term funding mechanisms, so clinical and diagnostic solutions are realized and recognized to combat unmet medical needs.",
author = "Mhashilkar, {Abner M.} and Anthony Atala",
year = "2012",
month = "11",
day = "1",
language = "English",
volume = "7",
pages = "430--445",
journal = "Current Stem Cell Research and Therapy",
issn = "1574-888X",
publisher = "Bentham Science Publishers B.V.",
number = "6",

}

TY - JOUR

T1 - Advent and maturation of regenerative medicine.

AU - Mhashilkar, Abner M.

AU - Atala, Anthony

PY - 2012/11/1

Y1 - 2012/11/1

N2 - The field of regenerative medicine (RM), encompassing stem cell (SC) technologies, therapeutics, tissue engineering (TE), biomaterials, scaffolds and other enabling technologies provides a wide gamut of tools and tracks to combat, manage and hopefully cure serious human and animal injuries, dysfunctions and diseases. This review illustrates the trends that are becoming the major platforms in this field. The last 10 years in itself has seen major definitive observations, including multi-track directives of adult stem cell translational technologies, tissue and organ engineering protocols, iPS cell applications and understanding of the role of cancer stem cells to develop effective anti-cancer regimens. With the rapid advances of RM translational research, further advances are expected to be implemented for personalized repair and curative outcomes. RM future is bright although laden with challenges of global fragmentation which needs coherent consolidation, stringent cost and time effective regulation and long-term funding mechanisms, so clinical and diagnostic solutions are realized and recognized to combat unmet medical needs.

AB - The field of regenerative medicine (RM), encompassing stem cell (SC) technologies, therapeutics, tissue engineering (TE), biomaterials, scaffolds and other enabling technologies provides a wide gamut of tools and tracks to combat, manage and hopefully cure serious human and animal injuries, dysfunctions and diseases. This review illustrates the trends that are becoming the major platforms in this field. The last 10 years in itself has seen major definitive observations, including multi-track directives of adult stem cell translational technologies, tissue and organ engineering protocols, iPS cell applications and understanding of the role of cancer stem cells to develop effective anti-cancer regimens. With the rapid advances of RM translational research, further advances are expected to be implemented for personalized repair and curative outcomes. RM future is bright although laden with challenges of global fragmentation which needs coherent consolidation, stringent cost and time effective regulation and long-term funding mechanisms, so clinical and diagnostic solutions are realized and recognized to combat unmet medical needs.

UR - http://www.scopus.com/inward/record.url?scp=84879515352&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879515352&partnerID=8YFLogxK

M3 - Article

C2 - 23176292

AN - SCOPUS:84879515352

VL - 7

SP - 430

EP - 445

JO - Current Stem Cell Research and Therapy

JF - Current Stem Cell Research and Therapy

SN - 1574-888X

IS - 6

ER -